四川医学2012，Vol.33Issue(2)：223-224,2.
急诊PCI替罗非班预防无复流的作用
The efficacy of tirofiban during primary percutaneous coronary intervention in the patients with acute coronary syndrome with no-reflow phenomenon
陈劲松 1速晓华 1李刚 1朱峻 1唐兵1
作者信息
- 1. 成都军区总医院心血管内科,四川成都610083
- 折叠
摘要
Abstract
Objective To assess the efficacy of tirofiban in the patients with Acute Coronary Syndrome who had no-reflow phenomenon after primary percutaneous coronary intervention. Methods From January 2009 to July 2010, according to exercise with or without tirofiban ,the patients with acute coronary syndrome divided into Tirofiban group (n =50) and control group (n= 40). The Tirofiban group was given Tirofiban during surgery followed by 10μg/kg. The control group underwent routine PCI surgery without Tirofiban infusion. The basis of clinical records, the occurrence of no-reflow phenomenon of the two groups were observed in the patients with primary PCI. Results Compared with the control group, the incidences of no-reflow phenomenon were significantly decreased in the tirofiban group (P <0. 05). Conclusion Enhancing anti-blood platelet therapy can effectively decrease the no-reflow phenomenon during primary PCI.关键词
急诊/PCI/替罗非班/无复流Key words
primary/percutaneous coronary intervention/tirofiban/no-flow phenomenon分类
医药卫生引用本文复制引用
陈劲松,速晓华,李刚,朱峻,唐兵..急诊PCI替罗非班预防无复流的作用[J].四川医学,2012,33(2):223-224,2.
